STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2015

STOCK-BASED COMPENSATION

Schedule of assumptions used to estimate the fair values of the stock options granted

	Three Months Ended
	March 31, 2015
Risk-free interest rate	1.8		%
Expected volatility	68.4		%
Expected life (in years)	6.9
Forfeiture rate	5.0		%
Dividend yield	—
Weighted-average estimated fair value of options granted during the period	$	0.99

Summary of stock options activity

	Options Outstanding
	Number of Shares		Weighted– Average Exercise Price		Weighted– Average Remaining Contractual Term (in years)	Weighted– Average Grant–Date Fair Value		Aggregate Intrinsic Value(1)
Balance at January 1, 2015	—		$	—	—	$	—	$	—
Options granted	1,964,665		1.52		—	0.99		(2,240		)
Exercised	—		—		—	—		—
Canceled/forfeited	(210,000	)	1.52		—	0.99		240
Balance at September 30, 2015	1,754,665		1.52		9.36	0.99		(2,000		)
Vested and exercisable as of September 30, 2015	—		—		—	—		—
Vested and exercisable as of September 30, 2015 and expected to vest thereafter	1,638,577		1.52		9.36	0.99		(1,868		)

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $0.38 of the Company’s common stock on September 30, 2015.

Summary of restricted common stock activity

	Unvested Restricted Shares
	Number of Shares		Weighted– Average Grant–Date Fair Value
Unvested at January 1, 2015	7,379		$	—
Granted	184,761		$	—
Vested	(63,439	)	$	—
Canceled	—		$	1.62
Unvested at September 30, 2015	128,701		$	—
Expected to vest after September 30, 2015	128,701		$	—

Schedule of stock-based compensation expense

	Three Months Ended September 30				Nine Months Ended September 30
	2015		2014		2015		2014
Cost of sales	$	—	$	—	$	—	$	—
Selling, general and administrative expense	$	178	$	322	$	553	$	1,023
Research and development expense	$	—	$	—	$	—	$	—
Total stock-based compensation expense	$	178	$	322	$	553	$	1,023
Total option exercise recognized tax benefit	$	—	$	—	$	—	$	—